Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome - PubMed (original) (raw)
Affiliations
- PMID: 12851722
Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome
Susumu Tanaka et al. Int J Mol Med. 2003 Aug.
Abstract
The disturbance of the central nervous system and immunological abnormalities have been suggested in patients with chronic fatigue syndrome (CFS). We focused on immunological abnormalities against neurotransmitter receptors in CFS. Using a sensitive radioligand assay, we examined serum autoantibodies to recombinant human muscarinic cholinergic receptor 1 (CHRM1), mu-opioid receptor (OPRM1), 5-hydroxytryptamine receptor 1A (HTR1A), and dopamine receptor D2 (DRD2) in patients with CFS (n=60) and results were compared with those in patients with autoimmune disease (n=33) and in healthy controls (n=30). The mean anti-CHRM1 antibody index was significantly higher in patients with CFS (p<0.0001) and autoimmune disease (p<0.05) than that in healthy controls, and positive reaction was found in 53.3% of patients with CFS. Anti-OPRM1 antibodies, anti-HTR1A antibodies, and anti-DRD2 antibodies were found in 15.2, 1.7, and 5.0% of patients with CFS, respectively. Anti-nuclear antibodies were found in 56.7% (34/60) of patients with CFS, but anti-nuclear antibody titers did not correlate with the activities of the above four autoantibodies. The patients with positive autoantibodies to CHRM1 had a significantly higher mean score (1.81) of 'feeling of muscle weakness' than negative patients (1.18) among CFS patients (p<0.01). Higher scores on 'painful node', 'forgetfulness', and 'difficulty thinking' were also found in CFS patients with anti-CHRM1 antibodies but did not reach statistical significance. In conclusion, autoantibodies to CHRM1 were detected in a large number of CFS patients and were related to CFS symptoms. Our findings suggested that subgroups of CFS are associated with autoimmune abnormalities of CHRM1.
Similar articles
- Autoantibodies against four kinds of neurotransmitter receptors in psychiatric disorders.
Tanaka S, Matsunaga H, Kimura M, Tatsumi Ki, Hidaka Y, Takano T, Uema T, Takeda M, Amino N. Tanaka S, et al. J Neuroimmunol. 2003 Aug;141(1-2):155-64. doi: 10.1016/s0165-5728(03)00252-2. J Neuroimmunol. 2003. PMID: 12965267 - Autoantibodies, polymorphisms in the serotonin pathway, and human leukocyte antigen class II alleles in chronic fatigue syndrome: are they associated with age at onset and specific symptoms?
Ortega-Hernandez OD, Cuccia M, Bozzini S, Bassi N, Moscavitch S, Diaz-Gallo LM, Blank M, Agmon-Levin N, Shoenfeld Y. Ortega-Hernandez OD, et al. Ann N Y Acad Sci. 2009 Sep;1173:589-99. doi: 10.1111/j.1749-6632.2009.04802.x. Ann N Y Acad Sci. 2009. PMID: 19758204 - Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome.
Loebel M, Grabowski P, Heidecke H, Bauer S, Hanitsch LG, Wittke K, Meisel C, Reinke P, Volk HD, Fluge Ø, Mella O, Scheibenbogen C. Loebel M, et al. Brain Behav Immun. 2016 Feb;52:32-39. doi: 10.1016/j.bbi.2015.09.013. Epub 2015 Sep 21. Brain Behav Immun. 2016. PMID: 26399744 - Infection, vaccination, and autoantibodies in chronic fatigue syndrome, cause or coincidence?
Ortega-Hernandez OD, Shoenfeld Y. Ortega-Hernandez OD, et al. Ann N Y Acad Sci. 2009 Sep;1173:600-9. doi: 10.1111/j.1749-6632.2009.04799.x. Ann N Y Acad Sci. 2009. PMID: 19758205 Review. - Chronic fatigue syndrome: characteristics and possible causes for its pathogenesis.
Bassi N, Amital D, Amital H, Doria A, Shoenfeld Y. Bassi N, et al. Isr Med Assoc J. 2008 Jan;10(1):79-82. Isr Med Assoc J. 2008. PMID: 18300582 Review.
Cited by
- A Role for the Intestinal Microbiota and Virome in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)?
Navaneetharaja N, Griffiths V, Wileman T, Carding SR. Navaneetharaja N, et al. J Clin Med. 2016 Jun 6;5(6):55. doi: 10.3390/jcm5060055. J Clin Med. 2016. PMID: 27275835 Free PMC article. Review. - The Pathobiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Case for Neuroglial Failure.
Renz-Polster H, Tremblay ME, Bienzle D, Fischer JE. Renz-Polster H, et al. Front Cell Neurosci. 2022 May 9;16:888232. doi: 10.3389/fncel.2022.888232. eCollection 2022. Front Cell Neurosci. 2022. PMID: 35614970 Free PMC article. - A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behavior.
Morris G, Anderson G, Galecki P, Berk M, Maes M. Morris G, et al. BMC Med. 2013 Mar 8;11:64. doi: 10.1186/1741-7015-11-64. BMC Med. 2013. PMID: 23497361 Free PMC article. Review. - Orthostatic Challenge Causes Distinctive Symptomatic, Hemodynamic and Cognitive Responses in Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Vernon SD, Funk S, Bateman L, Stoddard GJ, Hammer S, Sullivan K, Bell J, Abbaszadeh S, Lipkin WI, Komaroff AL. Vernon SD, et al. Front Med (Lausanne). 2022 Jun 23;9:917019. doi: 10.3389/fmed.2022.917019. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35847821 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials